The perils of portliness: Causes and consequences of visceral adiposity

Diabetes

Volumn 49, Issue 6, 2000, Pages 883-888

  Montague, Carl T ^b   O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; BODY DISTRIBUTION; BODY FAT; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; DIABETIC OBESITY; HUMAN; LIPID STORAGE; METABOLIC DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS FAT; VASCULAR DISEASE; VISCERA;

EID: 0034119138     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.883     Document Type: Review

References (74)

1. Seidell JC: Time trends in obesity: an epidemiological perspective. Horm Metab Res 29:155-158, 1997
2. Vague J: The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 4:20-34, 1956
3. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U: Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 72:1150-1162, 1983
4. Ohlson L, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus. Diabetes 34:1055-1058, 1985
5. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261, 1984
6. Kissebah AH, Vydelingum N, Murray M, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
7. Gillum RF: The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years. J Chronic Dis 40:421-428, 1987
8. Kannel WB, Cupples LA, Ramaswami R, Stokes J, Kreger BE, Higgins M: Regional obesity and risk of cardiovascular disease: the Framingham study. J Clin Epidemiol 44:183-190, 1991
9. Evans DJ, Murray R, Kissebah AH: Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding: effects of obesity and body fat topography. J Clin Invest 74:1515-1525, 1984
10. Ross R, Leger L, Morris D, de Guise J, Guardo R: Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 72:787-795, 1992
11. Ross R, Shaw KD, Rissanen J, Martel Y, de Guise J, Avruch L: Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr 57:470-475, 1993
12. Peiris AN, Hennes MI, Evans DJ, Wilson CR, Lee MB, Kissebah AH: Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. Acta Med Scand Suppl 723:179-188, 1988
13. Fujioka S, Matsuzawa Y, Tokunaga K, Kawamoto T, Kobatake T, Keno Y, Kotani K, Yoshida S, Tarui S: Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 15:853-859, 1990
14. Riches FM, Watts GF, Hua J, Stewart GR, Naoumova RP, Barrett PHR: Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. J Clin Endocrinol Metab 84:2854-2861, 1999
15. Albu JB, Curi M, Shur M, Murphy L, Matthews DE, Pi-Sunyer FX: Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity. Am J Physiol 277:E551-E560, 1999
16. Barzilai N, She L, Liu B-Q, Vuguin P, Cohen P, Wang J, Rossetti L: Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48:94-98, 1999
17. Comuzzie A, Allison D: The search for human obesity genes. Science 280:1374-1377, 1998
18. Bouchard C, Rice T, Lemieux S, Despres J-P, Perusse L, Rao DC: Major gene for abdominal visceral fat area in the Quebec Family Study. Int J Obes 20:420-427, 1996
19. Bouchard C, Després J-P, Mauriége P: Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 34:72-93, 1993
20. Vague J, Meignen JM, Negrin JF: Effects of testosterone and estrogens on deltoid and trochanter adipocytes in two cases of transsexualism. Horm Metab Res 16:380-381, 1984
21. Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ: Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab 82:2044-2047, 1997
22. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Early AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908, 1997
23. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte J, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guygrand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401, 1998
24. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson M-L, Sanders L, Montague CT, Hutton JC, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the prohormone convertase 1 gene. Nat Genet 16:303-306, 1997
25. Krude H, Biebermann H, Luck W, Horn R, Brahant G, Gruters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157, 1998
26. Yeo G, Farooqi I, Aminian S, Halsall D, Stanhope R, O'Rahilly S: A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20:111-112, 1998
27. Ristow M, Mulllerwieland D, Pfeiffer A, Krone W, Kahn C: Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 339:953-959, 1998
28. Cao H, Hegele RA: Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Gen 9:109-112, 2000
29. Shackleton S, Lloyd DJ, Jackson SNJ, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, Gregory S, O'Rahilly S, Trembath RC: LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24:153-156, 2000
30. Moller D, Chang P, Yaspelkis B, Flier J, Wallberg-Henriksson H, Ivy J: Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia. Endocrinology 137:2397-2405, 1996
31. Bruning J, Michael MD, Winnay J, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CJ: A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569, 1998
32. Schwartz M, Boyko E, Kahn S, Ravussin E, Bogardus C: Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab 80:1571-1576, 1995
33. Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiol Rev 74:761-811, 1994
34. Nagy K, Levy J, Grunberger G: High-fat feeding induces tissue-specific alteration in proportion or activated insulin receptors in rats. Acta Endocrinol 122:361-368, 1990.
35. Hennes MMI, Shrago E, Kissebah AH: Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obes 14:831-841, 1990
36. Jensen M: Health consequences of fat distribution. Horm Res 48:88-92, 1997
37. Rebuffé-Serive M, Andersson B, Olbe L, Björntorp P: Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism 38:453-458, 1989
38. Hellmér J, Marcus C, Sonnenfeld T, Arner P: Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 75:15-20, 1992
39. Arner P, Hellstrom L, Wahrenberg H, Bronnegard M: Beta-adrenoceptor expression in human fat cells from different regions. J Clin Invest 86:1595-1600, 1990
40. Vikman H-L, Savola J-M, Raasmaja A, Ohisalo JJ: α2A-Adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. Int J Obes 20:185-189, 1996
41. Bolinder J, Kager L, Ostman J, Arner P: Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32:117-123, 1983
42. Zierath J, Livingston J, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, Arner P: Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41:1343-1354, 1998
43. Lefebvre A-M, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, Vidal H: Depotspecific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47:98-103, 1998
44. Marin P, Lönn L, Andersson B, Odén B, Olbe L, Bengtsson B-A, Bjöntorp P: Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissue in vivo in men: effects of testosterone. J Clin Endocrinol Metab 81:1018-1022, 1996
45. Fried SK, Russell CD, Grauso NL, Brolin RE: Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92:2191-2198, 1993
46. Rebuffé-Scrive M, Bronnegard M, Nilsson A, Eldh J, Gustafsson J-A, Bjorntorp P: Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 71:1215-1219, 1990
47. Bujalska IJ, Kumar S, Stewart PM: Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213, 1997
48. Rebuffé-Serive M, Lönnroth P, Märin P, Wesslau C, Björntorp P, Smith U: Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes 11:347-355, 1987
49. Marin P, Odén B, Björntorp P: Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80:239-243, 1995
50. Dieudonne M, Pecquery R, Boumediene A, Leneveu M, Giudicelli Y: Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274:C1645-C1652, 1998
51. Pedersen SB, Hanses PS, Lund S, Andersen PH, Odgaard A, Richelsen B: Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue. Eur J Clin Invest 26:262-269, 1996
52. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
53. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumour necrosis factor-α direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
54. Fried S, Bunkin D, Greenberg A: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6 depot difference and regulation by glucocorticoid. J Clin Endocrinol 83:847-850, 1998
55. Cook KC, Min HY, Johnson D, Chaplinsky RJ, Flier JS, Hunt CR, Spiegelman BM: Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 237:402-404, 1987
56. Saleh J, Summers L, Cianflone K, Fielding B, Sniderman A, Frayn K: Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 39:884-891, 1998
57. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867, 1997
58. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression. Diabetes 46:342-347, 1997
59. Bennett F, Mcfarlane-Anderson N, Wilks R, Luke A, Cooper R, Forrester T: Leptin concentration in women is influenced by regional distribution of adipose tissue. Am J Clin Nutr 66:1340-1344, 1997
60. Harmelen W, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P: Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47:913-917, 1998
61. Rossetti L, Massillon D, Barzilai N, Vuguin P, Chen W, Hawkins M, Wu J, Wang J: Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 272:27758-27763, 1997
62. Sivitz W, Walsh S, Morgan D, Thomas M, Haynes W: Effects of leptin on insulin sensitivity in normal rats. Endocrinology 138:3395-3401, 1997
63. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803, 1996
64. Eriksson P, Reynisdottir S, Lönnqvist F, Stemme V, Hamsten A, Arner P: Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 41:65-71, 1998
65. Niesler C, Siddle K, Prins J: Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 47:1365-1368, 1998
66. Montague C, Prins J, Sanders L, Zhang J, Sewter C, Digby J, Byrne C, O'Rahilly S: Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47:1384-1391, 1998
67. Hauner H, Wabitsch M, Pfeiffer EF: Differentiation of adipocyte precursor cells from obese and nonobese adult, women and from different adipose tissue sites. Horm Metab Res Suppl 19:35-39, 1988
68. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156, 1994
69. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman B, Evans RM: 15-Deoxy-12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812, 1995
70. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Sewter CP, Digby JE, Lazar MA, Chatterjee VKK, O'Rahilly S: Activators of PPARγ have depot-specific effects on human pre-adipocyte differentiation. J Clin Invest 100:3149-3153, 1997
71. Burris T, Pelton P, Zhou L, Osborne M, Cryan E, Demarest K: A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activaled receptor gamma agonist actions on ap2 gene expression detected using branched DNA messenger RNA quantitation. Mol Endocrinol 13:410-417, 1999
72. Kelly I, Han T, Walsh K, Lean M: Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 22:288-293, 1999
73. Mori Y, Murakawa Y, Okada K, Horikoshi H, Yokoyama J, Tajima N, Ikeda Y: Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22:908-912, 1999
74. Yanase T, Yashiro T, Takitani K, Kato S, Taniguchi S, Takayanagi R, Nawata H: Differential expression of PPARγ1 and γ2 isoforms in human adipose tissue. Biochem Biophys Res Commun 233:320-324, 1997